Insights

Join us on Wednesday, January 22, 2025 — in-person or live-streaming — at the next Midwest Cyber Security Alliance meeting where sponsor Netrix Global will explore how robust data governance is key to harnessing the power of generative AI responsibly.

Join us to kick off the festivities on Monday, January 13 at SHACK15 for a lovely evening with colleagues and entrepreneurs across Life Sciences.

Start the new year with Foley & Lardner and PYA at the seventh annual Let's Talk Compliance virtual conference.

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.

The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.

The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.

In this episode, Let’s Talk Compliance Hosts Jana Kolarik a partner of Foley’s Health Care Practice Group and PYA principal Angie Caldwell, discuss physician compensation plans and the latest trends in physician compensation of 2024.

It’s election season, which means there are almost as many campaign commercials as there are pumpkin-spiced treats these days. But what does the campaign trail tell us about the future of energy policy in Washington?

In this episode, partner Jana Kolarik of Foley’s Health Care Practice Group and PYA principal Angie Caldwell host Heidi Jeffery, a partner in Foley’s Finance and Financial Institutions Practice Group and Matt Stuart, a Principal in PYA’s Audit Assurance Service Line, discuss the latest trends in the bond market and the bond compliance pitfalls that organizations should avoid.

Since 2018, licensing deals totaling over $60 billion have been signed regarding Antibody Drug Conjugates (ADCs), with 2023 alone having at least 18 deals.

As we make further strides into 2024, the fashion, apparel & beauty landscape continues its dynamic evolution, marked by opportunities and challenges.

Foley & Lardner’s 2024 Health Care & Life Sciences Top Trends publication unpacks fast-moving developments to help your business.

As service providers, ICHRA vendors are tasked with assisting their employer-clients with the regulatory requirements imposed on the ICHRA plan, as well as focusing on their own compliance responsibilities as a third-party administrator and insurance agency, where applicable. 

This article is the seventh and final in our series on equity-based compensation. It will provide an overview of special considerations for publicly-traded companies when granting equity awards, including the impact of proxy advisory firms on plan design, grant timing considerations, compliance with Section 16 of the Securities Exchange Act of 1934 (Section 16), and Securities and Exchange Commission (SEC) registration requirements.

So, for those of you who missed last year’s “The Grinch Who Stole Compliance,” never fear: We have an endless supply of compliance-related holiday mirth.